Anti-inflammatory effects of amarogentin on 2,4-dinitrochlorobenzene-induced atopic dermatitis-like mice and in HaCat cells.
Anti-inflammatory effects of amarogentin on 2,4-dinitrochlorobenzene-induced atopic dermatitis-like mice and in HaCat cells.
复制标题
DOI:
10.1002/ame2.12260
复制
发表时间:
2023-06
影响因子:
3.7
通讯作者:
Chen, Si
中科院分区:
文献类型:
--
作者:
Zhang, Qian;Wang, Hanlin;Ran, Cheng;Lyu, Yansi;Li, Fei;Yao, Yihang;Xing, Shaojun;Wang, Li;Chen, Si
Amarogentin (AMA) is a secoiridoid glycoside extracted from Swertia and Gentiana roots and exhibits many biological effects such as antioxidative, anti‐inflammatory, and antitumor activities. Atopic dermatitis (AD) is a chronic inflammatory skin disease caused by disorders in the regulation of multiple inflammatory cytokines. No effective cure has been found for AD now. We constructed the HaCat and splenocyte model and tested the inhibitory effect of AMA on IL‐4, IL‐6, and IL‐13 secretions using enzyme‐linked immunosorbent assay (ELISA). The AD mouse model was constructed and treated with AMA, the severity of skin lesions was observed, epidermal tissue was collected, and epidermal thickness and mast cell infiltration were observed using hematoxylin and eosin and toluidine blue staining, respectively. The expression of kallikrein‐related peptidase 7 (KLK7) and filaggrin (FLG) was detected using immunostaining and Western blot analysis. The mRNA expression of KLK7 and FLG was detected using quantitative polymerase chain reaction (qPCR). Blood immunoglobulin E (IgE) secretion was detected. AMA inhibited IL‐6 secreted by tumor necrosis factor (TNF)‐α‐induced HaCaT cells and reduced IL‐4 and IL‐13 secreted by phytohemagglutinin (PHA)‐induced primary cells in the mice spleen. It was found that the treatment of AMA with 2,4‐dinitrochlorobenzene‐induced AD‐like mice could promote the recovery of dermatitis, reduce the score of dermatitis severity and the scratching frequency, treat the skin lesions, reduce the epidermal thickness, decrease the infiltration of mast cells, reduce the IgE level in serum, decrease the expression levels of AD‐related cytokines, increase protein and mRNA expression of FLG, and reduce the protein and mRNA expression of KLK7 in the skin tissues of AD‐like mice. In conclusion, AMA inhibits inflammatory response at the cellular level, and AMA reduces the validation response of specific dermatitis mice, relieves pruritus, and repairs the damaged skin barrier. This study confirmed the therapeutic effect of AMA on atopic dermatitis in vivo and in vitro. We confirmed that AMA can inhibit the expression of IL‐4, 6 and 13 with HaCaT cells and mouse kidney cells. In AD mouse model, H&E, TB staining, immunohistochemistry, Western blot, qPCR and ELISA were used to confirm the effect of AMA on AD.
登录
查看更多内容
DOI:
10.1084/jem.20082242
发表时间:
2009-05-11
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Briot A;Deraison C;Lacroix M;Bonnart C;Robin A;Besson C;Dubus P;Hovnanian A
通讯作者:
Hovnanian A
DOI:
10.4168/aair.2018.10.3.207
发表时间:
2018-05
期刊:
Allergy, asthma & immunology research
影响因子:
--
作者:
Kim BE;Leung DYM
通讯作者:
Leung DYM
影响因子:
--
作者:
Ku JM;Hong SH;Kim HI;Seo HS;Shin YC;Ko SG
通讯作者:
Ko SG
影响因子:
14.2
作者:
Hanifin, JM;Tofte, SJ
通讯作者:
Tofte, SJ
影响因子:
3.4
作者:
Huang, Xia;Xu, Bo
通讯作者:
Xu, Bo